Early trial tests stem cell particles for rare Muscle-Weakening disorder
NCT ID NCT07226726
Summary
This early-stage study is testing whether a solution containing particles from stem cells (called exosomes) can help people with congenital myasthenic syndrome, a rare genetic disorder that causes muscle weakness. The trial will enroll 20 participants to see if the treatment is safe and to measure changes in their oxygen levels. This is a first step to see if the approach has potential before larger studies are conducted.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL MYASTHENIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical Surgical Associates Center
RECRUITINGSt John's, Antigua and Barbuda
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prodromos Stem Cell Institute
RECRUITINGNaples, Florida, 34102, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prodromos Stem Cell Institute
RECRUITINGIrving, Texas, 75039, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.